Altamira Therapeutics CYTOF
OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Altamira Therapeutics (CYTOF) Common Equity (2013 - 2025)

Updated

Altamira Therapeutics (CYTOF) reported Common Equity of $4.07 million for Q2 2025, down 35.5% from $6.32 million a year earlier.

Analysis

Altamira Therapeutics (CYTOF) Common Equity (2013 - 2025) Analysis & Trends

At the end of FY2024, Altamira Therapeutics posted Common Equity of $6.57 million, down 14.5% from FY2023.

  • Common Equity has a five-year compound annual growth rate of 1.5% (FY2019 to FY2024).
  • By year, Common Equity came in at $7.68 million in FY2023, -$8.99 million in FY2022, $14.31 million in FY2021 (-22.9%) and $18.55 million in FY2020 (+204.2%).
  • The Q2 2025 figure ranks as the lowest quarterly Common Equity since Q2 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 4.07 Mn
Dec 31, 2024 6.57 Mn
Jun 30, 2024 6.32 Mn
Dec 31, 2023 7.66 Mn
Jun 30, 2023 -2.03 Mn
Jan 1, 2023 -8.99 Mn
Dec 31, 2022 -9.01 Mn
Jun 30, 2022 7.07 Mn
Dec 31, 2021 14.27 Mn
Jun 30, 2021 21.81 Mn
Dec 31, 2020 19.02 Mn
Jun 30, 2020 4.71 Mn
Dec 31, 2019 6.23 Mn
Jun 30, 2019 9.17 Mn
Dec 31, 2018 3.71 Mn
Sep 30, 2018 -758,477.16
Jun 30, 2018 -3.56 Mn
Mar 31, 2018 -1.48 Mn
Dec 31, 2017 -2.21 Mn
Sep 30, 2017 99.18 Mn
API Access

Altamira Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CYTOF&period=max&api_key=YOUR_API_KEY